Clinical Trials
3
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (100.0%)YQ23 Study in Patients With Critical Limb Ischaemia
Phase 1
Terminated
- Conditions
- Critical Limb Ischemia
- First Posted Date
- 2021-03-10
- Last Posted Date
- 2023-12-08
- Lead Sponsor
- New Beta Innovation Limited
- Target Recruit Count
- 5
- Registration Number
- NCT04792008
- Locations
- ðŸ‡ðŸ‡°
Prince of Wales Hospital, Sha Tin, New Territories, Hong Kong
ðŸ‡ðŸ‡°Queen Mary Hospital, Hong Kong, Hong Kong
A Safety Study of YQ23 in Advanced Solid Tumors Patients
Phase 1
Terminated
- Conditions
- Advanced Solid Tumor
- First Posted Date
- 2020-08-14
- Last Posted Date
- 2023-12-08
- Lead Sponsor
- New Beta Innovation Limited
- Target Recruit Count
- 3
- Registration Number
- NCT04513067
- Locations
- ðŸ‡ðŸ‡°
The University of Hong Kong Phase I Clinical Trials Centre, Hong Kong, Hong Kong
First-In-Man, Healthy Volunteer Study to Evaluate Safety on the Use of YQ23
Phase 1
Completed
- Conditions
- Healthy Volunteers
- First Posted Date
- 2019-01-14
- Last Posted Date
- 2021-03-03
- Lead Sponsor
- New Beta Innovation Limited
- Target Recruit Count
- 58
- Registration Number
- NCT03802292
- Locations
- 🇬🇧
Covance CRU Limited, Leeds, United Kingdom
News
No news found